全文获取类型
收费全文 | 1595篇 |
免费 | 87篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 61篇 |
儿科学 | 57篇 |
妇产科学 | 46篇 |
基础医学 | 188篇 |
口腔科学 | 17篇 |
临床医学 | 116篇 |
内科学 | 315篇 |
皮肤病学 | 24篇 |
神经病学 | 123篇 |
特种医学 | 33篇 |
外科学 | 284篇 |
综合类 | 36篇 |
预防医学 | 80篇 |
眼科学 | 56篇 |
药学 | 88篇 |
中国医学 | 6篇 |
肿瘤学 | 153篇 |
出版年
2023年 | 14篇 |
2022年 | 40篇 |
2021年 | 60篇 |
2020年 | 39篇 |
2019年 | 41篇 |
2018年 | 62篇 |
2017年 | 38篇 |
2016年 | 51篇 |
2015年 | 52篇 |
2014年 | 62篇 |
2013年 | 99篇 |
2012年 | 137篇 |
2011年 | 138篇 |
2010年 | 89篇 |
2009年 | 78篇 |
2008年 | 93篇 |
2007年 | 90篇 |
2006年 | 97篇 |
2005年 | 85篇 |
2004年 | 66篇 |
2003年 | 69篇 |
2002年 | 67篇 |
2001年 | 20篇 |
2000年 | 17篇 |
1999年 | 15篇 |
1998年 | 6篇 |
1997年 | 5篇 |
1996年 | 6篇 |
1995年 | 7篇 |
1994年 | 4篇 |
1993年 | 5篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 3篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 5篇 |
1967年 | 1篇 |
1964年 | 1篇 |
排序方式: 共有1683条查询结果,搜索用时 0 毫秒
61.
62.
63.
64.
Damodar S Viswabandya A George B Mathews V Chandy M Srivastava A 《European journal of haematology》2005,75(4):328-331
Data on 90 patients (55 adults and 35 children) with chronic idiopathic thrombocytopenic purpura (ITP) and a platelet count of <50 x 10(9)/L treated with dapsone at a dose of 1-2 mg/kg/d are presented. A response was observed in 57 (63.3%) patients. The average time for response was 3.5 months (range 1-9) and the average duration of treatment with dapsone was 10.4 months (range 4-14). Overall response rates of 65.7% and 61.8% were observed in children and adults respectively. Side effects requiring discontinuation of therapy were observed in three (2%) patients. These results demonstrate that dapsone is an effective, inexpensive and well-tolerated treatment for chronic ITP, in both children and adults and could be considered for patients who fail steroid therapy. 相似文献
65.
Mathews V Viswabandya A Baidya S George B Nair S Chandy M Srivastava A 《Seminars in thrombosis and hemostasis》2005,31(5):538-543
Surgical interventions in patients with hemophilia (PWH) in the developing world are difficult in the setting of limited availability of factor concentrates. Although the adequacy of international guidelines for factor concentrate prophylaxis for PWH undergoing surgery has been established, frequently it is not practical in the developing world. These recommendations were not established based on large clinical trials and fail to define the safe lower limit of factor concentrate prophylaxis for surgery. The need to define these lower limits is essential in the developing world so that the limited resources may be used optimally for the cohort of PWH. There are limited data from the developing world with regard to PWH undergoing surgical procedures. In this article, we outline experience from our institution, a tertiary referral center for hemophilia care in India. We trace the basis on which our current factor concentrate prophylaxis regimen (which is lower than that recommended internationally) was established. In our experience our low-dose protocols are effective, reduce factor consumption by one third, and are not associated with a significantly increased risk of delayed hemorrhage. We hope that this experience will form a framework on which guidelines can be established for developing countries. 相似文献
66.
Alok Bhargava Aravinda M. Guntupalli Michael Lokshin Larry L. Howard 《Health economics》2014,23(5):606-620
Timely vaccinations of children in developing countries are important for reducing morbidity and mortality, which are Millennium Development Goals. However, a majority of children do not possess vaccination cards compiling information on timing. We investigated the benefits of vaccination cards for the uptake of immunizations against diphtheria, pertussis and tetanus (DPT), polio, tuberculosis (BCG), and measles using data on over 200,000 Indian children from the District Level Health and Facility Survey 3. Methodological issues such as whether parents of children with higher morbidity levels may have them vaccinated were investigated. The results from the models for DPT, polio, measles, and BCG vaccinations showed significant beneficial effects of maternal education, household possessions, and access to health care facilities. Moreover, models for children's ages at the time of vaccination showed significant interactions between maternal education and access to and availability of health care facilities. Finally, models for child morbidity due to diarrhea, cough, and fever showed that timely vaccinations against DPT, access to piped water, and cooking with electricity or natural gas were associated with lower morbidity. Overall, issuing paper or electronic vaccination cards to children is likely to enhance timely uptake of various immunizations thereby reducing child morbidity. Copyright © 2013 John Wiley & Sons, Ltd. 相似文献
67.
David J. Loane Bogdan A. Stoica Flaubert Tchantchou Alok Kumar James P. Barrett Titilola Akintola Fengtian Xue P. Jeffrey Conn Alan I. Faden 《NeuroRx》2014,11(4):857-869
Traumatic brain injury (TBI) causes microglial activation and related neurotoxicity that contributes to chronic neurodegeneration and loss of neurological function. Selective activation of metabotropic glutamate receptor 5 (mGluR5) by the orthosteric agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG), is neuroprotective in experimental models of TBI, and has potent anti-inflammatory effects in vitro. However, the therapeutic potential of CHPG is limited due to its relatively weak potency and brain permeability. Highly potent, selective and brain penetrant mGluR5 positive allosteric modulators (PAMs) have been developed and show promise as therapeutic agents. We evaluated the therapeutic potential of a novel mGluR5 PAM, VU0360172, after controlled cortical impact (CCI) in mice. Vehicle, VU0360172, or VU0360172 plus mGluR5 antagonist (MTEP), were administered systemically to CCI mice at 3 h post-injury; lesion volume, hippocampal neurodegeneration, microglial activation, and functional recovery were assessed through 28 days post-injury. Anti-inflammatory effects of VU0360172 were also examined in vitro using BV2 and primary microglia. VU0360172 treatment significantly reduced the lesion, attenuated hippocampal neurodegeneration, and improved motor function recovery after CCI. Effects were mediated by mGluR5 as co-administration of MTEP blocked the protective effects of VU0360172. VU0360172 significantly reduced CD68 and NOX2 expression in activated microglia in the cortex at 28 days post-injury, and also suppressed pro-inflammatory signaling pathways in BV2 and primary microglia. In addition, VU0360172 treatment shifted the balance between M1/M2 microglial activation states towards an M2 pro-repair phenotype. This study demonstrates that VU0360172 confers neuroprotection after experimental TBI, and suggests that mGluR5 PAMs may be promising therapeutic agents for head injury.
Electronic supplementary material
The online version of this article (doi:10.1007/s13311-014-0298-6) contains supplementary material, which is available to authorized users. 相似文献68.
69.
70.
G. Thiagamoorthy A. Johnson R. Thakar A. H. Sultan 《International urogynecology journal》2014,25(12):1621-1627